Articles published by Ovid Therapeutics Inc.
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics to Present at Upcoming September Investor Conferences
September 04, 2024
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
August 13, 2024
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
March 08, 2024
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
November 03, 2023
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
August 04, 2023
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer
June 28, 2023
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 10, 2023
Via GlobeNewswire
Tickers
OVID
![](https://ml.globenewswire.com/media/5f0a350f-f5e8-4292-93f5-5bdd581c009e/small/ovid-therapeutics-tm-rgb-jpg.jpg)
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023
Via GlobeNewswire
Tickers
OVID
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.